Cyclosporin is named as an intervention in 3 current clinical trials in our China, France and Netherlands registers. 3 are recruiting patients now. The most common phase is Phase 2/3. The sponsor with the most trials is Shanghai Jiaolian Drug Research and Development Co., Ltd (1). The most-studied condition is Primary Membranous Nephropathy.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness Study
NCT07381556 · ClinicalTrials.gov ↗ · Alopecia Areata(AA), Alopecia Areata (AA), Alopecia Totalis/Universalis
|
Phase 4 | Recruiting | Erasmus Medical Center | Netherlands |
|
A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.
NCT06470191 · ClinicalTrials.gov ↗ · Primary Membranous Nephropathy
|
Phase 2/3 | Recruiting | Shanghai Jiaolian Drug Research and Development Co., Ltd | China |
|
Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes
NCT05153070 · ClinicalTrials.gov ↗ · Type 1 Diabetes
|
Phase 2 | Recruiting | Assistance Publique - Hôpitaux de Paris | France |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| Shanghai Jiaolian Drug Research and Development Co., Ltd | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Erasmus Medical Center | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 1 | 1 |
| Clinical trials in France | 1 | 1 |
| Clinical trials in Netherlands | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
3 current trials in our China, France and Netherlands registers name Cyclosporin as a drug or biological intervention, as of the registry sync on 27 September 2026. Completed and withdrawn studies are not counted.
Yes. 3 of the 3 trials are recruiting: 1 with sites in China, 1 with sites in France and 1 with sites in Netherlands. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Shanghai Jiaolian Drug Research and Development Co., Ltd (1), Assistance Publique - Hôpitaux de Paris (1) and Erasmus Medical Center (1). The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Cyclosporin works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Cyclosporin works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Cyclosporin (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 27 Sep 2026.